FMI to launch digital oncology service at...At the opening ceremony for R&D, training and production buildings at Roche Penzberg, the Pharma giant said that Foundation Medicine (FMI) will establish a digital oncology service at the site offering … more ➔
Biocartis inks breast cancer R&D deal Belgian diagnostics company Biocartis Group NV and Singpores A*STAR ETPL have kicked off development of a multimodal breast cancer assay designed to guide therapy selection in personalised medici … more ➔
4SC AG raises €41m Small molecule cancer drug developer 4SC AG (Planegg-Martinsried, Germany) has completed a capital increase fueling development of its clinical programmes for resminostat, 4SC-202 and 4SC-208 more ➔
Success for individualised cancer vaccineGerman biotech company Biontech AG has published positive clinical results for its individualised cancer vaccine Ivac mutanome in patients with late-stage melanoma. more ➔
Seventure debuts in Japan with microbiome... Venture capitalist Seventure Partners announced that it has participated in a US$13m financing of Japanese biotech company Anaeropharma Science. The investment is made from Seventures Health for Life … more ➔
Noxxon/MSD start testing of immunoncologic...Last December, Noxxon Pharma AG signed an agreement with Merck & Co./MSD to evaluate the synergistic potential of NOXA1/2 and pembrolizumab immune cancer therapy. Now, the companies have kicked off … more ➔
Exscientia inks €37m contract with GSKBritish pharma giant GlaxoSmithKline has secured access to Ex Scientia Ltd (Exscientia)s artificial intelligence (AI)-driven drug discovery platform. more ➔
Breaking therapy resistance of follicular...Swiss researchers have found a way to prevent the multiple disease relapses after responses to follicular lymphoma therapy. more ➔
AML: Cellectis testing allogenic CAR-T cel... Genome editing specialist Cellectis has kicked off clinical tests in the US for the very first of-the-shelf CAR-T cell therapy in acute myeloid leukaemia. more ➔
Diabetes: J&J and Seventure Partners...European venture capitalist Seventure Partners and Johnson & Johnson have invested US$12m in Israel-based DayTwo. Based on HbA1c, lifestyle factors and genetic analysis of the individual microbiome, … more ➔
